BR112012010895A2 - "fornecimento de veículo". - Google Patents

"fornecimento de veículo".

Info

Publication number
BR112012010895A2
BR112012010895A2 BR112012010895A BR112012010895A BR112012010895A2 BR 112012010895 A2 BR112012010895 A2 BR 112012010895A2 BR 112012010895 A BR112012010895 A BR 112012010895A BR 112012010895 A BR112012010895 A BR 112012010895A BR 112012010895 A2 BR112012010895 A2 BR 112012010895A2
Authority
BR
Brazil
Prior art keywords
hard gelatin
delivery vehicle
carrier
loaded
gelatin capsule
Prior art date
Application number
BR112012010895A
Other languages
English (en)
Inventor
Delmarre David
Original Assignee
Capsugel Belgium Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Belgium Nv filed Critical Capsugel Belgium Nv
Publication of BR112012010895A2 publication Critical patent/BR112012010895A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

patente de invenção: "fornecimento de veículo". a presente invenção refere-se a novo veículo de fornecimento líquido compreendendo um grau específico de caprilato de glicerila e a óleo de rícino hidrogenado de peg-40 em quantidades particulares. esse veículo pode ser carregado com substâncias levemente ou pobremente solúveis em água e introduzidas para dentro de revestimentos de cápsula de gelatina dura para a administração final a um indivíduo. também revelado são composições de enchimento compreendendo tal veículo de fornecimento e cápsulas de gelatina dura enchidas com o veículo e a composição da invenção. o veículo de fornecimento da invenção provou ser compatível tanto com revestimentos de cápsula de gelatina dura quanto as substâncias carregadas para dentro dela.
BR112012010895A 2009-11-09 2010-10-26 "fornecimento de veículo". BR112012010895A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25935509P 2009-11-09 2009-11-09
US37752810P 2010-08-27 2010-08-27
PCT/IB2010/054844 WO2011055269A1 (en) 2009-11-09 2010-10-26 Delivery carrier

Publications (1)

Publication Number Publication Date
BR112012010895A2 true BR112012010895A2 (pt) 2019-09-24

Family

ID=43416906

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012010895A BR112012010895A2 (pt) 2009-11-09 2010-10-26 "fornecimento de veículo".

Country Status (12)

Country Link
US (1) US9333177B2 (pt)
EP (1) EP2498760B1 (pt)
JP (1) JP2013510135A (pt)
KR (1) KR20120105465A (pt)
CN (1) CN102711741A (pt)
AU (1) AU2010316741A1 (pt)
BR (1) BR112012010895A2 (pt)
CA (1) CA2779005A1 (pt)
EA (1) EA201290315A1 (pt)
MX (1) MX2012005264A (pt)
TW (1) TW201119690A (pt)
WO (1) WO2011055269A1 (pt)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178516B2 (en) * 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
GB9525194D0 (en) * 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
US5919481A (en) 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
JP2001515491A (ja) * 1997-03-12 2001-09-18 アボツト・ラボラトリーズ 親油性化合物の投与のための親油性二成分系
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20030104048A1 (en) 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
CA2537029C (en) * 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
WO2006063109A2 (en) * 2004-12-09 2006-06-15 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
KR20080009201A (ko) * 2005-04-15 2008-01-25 클라루스 쎄러퓨틱스, 아이엔씨. 소수성 약물의 약물전달시스템 및 이를 포함하는 조성물
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10

Also Published As

Publication number Publication date
AU2010316741A1 (en) 2012-05-24
JP2013510135A (ja) 2013-03-21
CA2779005A1 (en) 2011-05-12
EP2498760B1 (en) 2015-07-01
US9333177B2 (en) 2016-05-10
EA201290315A1 (ru) 2012-10-30
WO2011055269A1 (en) 2011-05-12
TW201119690A (en) 2011-06-16
CN102711741A (zh) 2012-10-03
MX2012005264A (es) 2012-07-03
EP2498760A1 (en) 2012-09-19
US20120308655A1 (en) 2012-12-06
KR20120105465A (ko) 2012-09-25

Similar Documents

Publication Publication Date Title
MX2021005389A (es) Formulaciones de nanoparticulas lipidicas.
NZ591810A (en) Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
CO6290641A2 (es) Preparacion de capsula que contiene los ingredientes farmaceuticamente activos liquidos y solidos, la cual presenta exelentes propiedades de los ingredientes farmaceuticamente activos
EP4342546A3 (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
CL2011002432A1 (es) Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
WO2011116963A3 (en) Lipid nanoparticle capsules
EP2304026A4 (en) NANOPARTICLE COMPOSITIONS FOR A NUCLEIC ACID DELIVERY SYSTEM
BR112014027834A2 (pt) composições de nanopartícula lipídica para entrega de oligonucleotídeos antissenso
WO2011133925A3 (en) Targeted and light-activated cytosolic drug delivery
BR112013000392B8 (pt) Composição farmacêutica contendo partícula de distribuição semelhante a vírion para moléculas de rna autorreplicantes e seu uso
JO2932B1 (en) Lyspro insulin compounds linked to PEG
BRPI0820308B8 (pt) composição farmacêutica compreendendo oxi-hidróxido de ferro em alta carga, seus usos e seus processos de preparação, e comprimido
WO2008070538A3 (en) Micellar nanoparticles comprising botulinum toxin
WO2009091576A3 (en) Parenteral formulations of dopamine agonists
WO2010033726A3 (en) Drug delivery composition comprising a self-assembled gelator
WO2008124505A3 (en) Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
SI1608346T1 (sl) Spojine za sproščanje zdravilnih učinkovin na osnovi alfa-hidroksi kislinskih estrov in postopki njihove uporabe
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
MX2012000132A (es) Farmaco masticable.
MX2009005984A (es) Formulaciones con alta concentracion de proteina que contiene manitol.
TN2009000088A1 (en) Packaging system for pharmaceutical compositions and kit for intravenous administration
NZ599395A (en) Antisense formulation
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
BR112012010895A2 (pt) "fornecimento de veículo".

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.